期刊文献+

消水方联合顺铂治疗恶性胸腔积液的临床观察 被引量:12

Clinical observation on the efficacy of Xiaoshui Decoction combined with Cisplatin in treating malignant pleural effusion
原文传递
导出
摘要 目的:观察口服消水方联合顺铂胸腔灌注治疗恶性胸腔积液的临床疗效。方法:118例恶性胸腔积液患者随机分为两组,治疗组65例采用口服中药消水方联合顺铂胸腔灌注,对照组53例单用顺铂胸腔灌注。以恶性胸腔积液的近期疗效、生活质量评分及临床症状积分为指标进行临床观察。结果:治疗组和对照组近期有效率分别为72.3%和66.1%,两组无显著性差异,但治疗组较对照组生活质量显著改善(P<0.05),症状明显缓解(P<0.05)。结论:消水方联合顺铂胸腔灌注治疗恶性胸腔积液,近期疗效未见明显提高,但可减轻症状,提高生活质量。 Objective: To observe the clinical efficacy of Xiaoshui Decoction combined with intrapleural perfusion of cisplatin in the treatment of malignant pleural effusion.Methods: 118 patients with malignant pleural effusion were randomly assigned to two groups.The treated group(included 65 patients) was treated with oral administration of Xiaoshui Decoction combined with intrapleural perfusion of cisplatin,and the control group(included 53 patients) was only treated with intrapleural perfusion of cisplatin.The effects of the short-term efficacy,quality of life scores and clinical symptom scores of malignant pleural effusion were evaluated.Results: The short-term efficacy of treated group and control group were 72.3% and 66.1% respectively,and no significant difference was found.In contrast,the quality of life of the treated group was significantly improved compared to that of the control group(P0.05),and so was the symptom remission(P0.05).Conclusion: The combined therapy of Xiaoshui Decoction and intrapleural perfusion of cisplatin did not show obvious improvement in short-term efficacy,but the therapy remarkably alleviated the symptoms and improved the quality of life.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2012年第4期1164-1166,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 "十一五"国家科技支撑计划课题(No.2006BAI11B01-01)~~
关键词 消水方 恶性胸腔积液 顺铂 临床观察 胸腔灌注 评分 Xiaoshui Decoction Malignant pleural effusion Cisplatin Clinical observation Intrapleural perfusion Evaluate score
  • 相关文献

参考文献2

二级参考文献10

共引文献22

同被引文献79

  • 1王三虎.燥湿相混致癌论[J].山东中医杂志,2005,24(1):3-5. 被引量:23
  • 2陈衍智,李萍萍,杨红.葶苈大枣泻肺汤加味在恶性胸腔积液治疗中的应用[J].中医药临床杂志,2006,18(1):76-77. 被引量:23
  • 3高学敏.中药学[M].北京:中国中医药出版社,2010:426.
  • 4郑莜萸.中国新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:374.
  • 5章元沛.药理学实验[M].北京:人民卫生出版社,1996.1.
  • 6贾博琦.现代临床实用药物手册[M].第2版.北京:北京科技大学出版社,2002.732.
  • 7李绍修.实用胸腔积液治疗学.北京:人民卫生出版社,2004:96.
  • 8孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2010:133-156.
  • 9Kelly L, Tomasz S, Farah J, et al. A genetic strategy involving a glycosyhransferase promoter and a lipid translocating enzyme to e- liminate cancer cells [ J ]. Glycoconjugate Journal, 2009, 19 (266) : 133 - 135.
  • 10石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2010:133-156.

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部